Literature DB >> 11909011

Options for prevention of HIV transmission from mother to child, with a focus on developing countries.

Louise Kuhn1, Ingrid Peterson.   

Abstract

Use of antiretroviral drugs among HIV-infected pregnant women in many developed countries has significantly reduced rates of mother-to-child HIV transmission, demonstrating that this route of transmission is amenable to intervention. Prevention of transmission in developing countries has proved to be more difficult, although recent advances in short-course antiretroviral drug interventions have made it an immediate possibility, rather than a distant hope as it was seen to be in the recent past. Non-antiretroviral drug interventions, including washing of the birth canal with antiseptic solution and micronutrient supplementation, have not been found to be effective at interrupting mother-to-child HIV transmission, but may have other benefits for maternal and child health. An important issue for developing countries is prevention of postnatal HIV transmission through breast feeding. In most developing countries, formula feeding is not a reasonable option, given the higher rates of mortality from diarrheal and respiratory disease associated with avoidance of all breast feeding. A promising new line of research has recently been broached with the findings from a study in South Africa, which demonstrated that exclusive breast feeding is associated with a significant reduction in postnatal transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909011     DOI: 10.2165/00128072-200204030-00006

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  116 in total

1.  Proposed definitions for in utero versus intrapartum transmission of HIV-1.

Authors:  Y J Bryson; K Luzuriaga; J L Sullivan; D W Wara
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

2.  15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.

Authors: 
Journal:  Lancet       Date:  1999-12-11       Impact factor: 79.321

3.  Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS).

Authors:  L A Kalish; J Pitt; J Lew; S Landesman; C Diaz; R Hershow; F B Hollinger; M Pagano; V Smeriglio; J Moye
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

4.  Trends in perinatal transmission of HIV/AIDS in the United States.

Authors:  M L Lindegren; R H Byers; P Thomas; S F Davis; B Caldwell; M Rogers; M Gwinn; J W Ward; P L Fleming
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

5.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

6.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

7.  A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.

Authors:  M Lallemant; G Jourdain; S Le Coeur; S Kim; S Koetsawang; A M Comeau; W Phoolcharoen; M Essex; K McIntosh; V Vithayasai
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

8.  Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1.

Authors:  E Menu; F X Mbopi-Keou; S Lagaye; S Pissard; P Mauclère; G Scarlatti; J Martin; M Goossens; G Chaouat; F Barré-Sinoussi; F X M'bopi Kéou
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

9.  Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru.

Authors:  R E Black; G Lopez de Romaña; K H Brown; N Bravo; O G Bazalar; H C Kanashiro
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1.

Authors:  L M Frenkel; L E Wagner; L M Demeter; S Dewhurst; R W Coombs; B L Murante; R C Reichman
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

View more
  2 in total

1.  HIV seroprevalence among the pregnant population and utilisation of integrated counselling and training centre facilities at a teaching hospital in Rural Maharashtra.

Authors:  Anita Kwatra; Vidyadhar B Bangal; Kunaal Shinde; Keyur Padaliya
Journal:  Australas Med J       Date:  2011-10-31

Review 2.  Nonmalarial infant deaths and DDT use for malaria control.

Authors:  Aimin Chen; Walter J Rogan
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.